Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathy

Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathy - Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033121

Enrollment

100

Registered

2018-07-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonischemic dilated cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: New-onset non-ischemic dilated cardiomyopathy patients initiating optimal medical therapy including ACE inhibitors and beta blockers.

Exclusion criteria

Exclusion criteria: Patients who couldn't complete MRI scan Patients having persistent left side vena cava Patients with eGFR<30ml/min/1.73m2

Design outcomes

Primary

Measure	Time frame
Left ventricular reverse remodeling by optimal medical therapy	—

Countries

Japan

Contacts

Public ContactShingo Kato

Kanagawa Cardiovascular and respiratory Center Department of Cardiology

shingo.m12226@gmail.com045-701-9581

Outcome results